PLSM Pulsenmore Ltd. Ordinary Shares
Healthcare$4.53+0.89%ClosedMarket Cap: $29.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.00
P/S
2.10
EV/EBITDA
-5.01
DCF Value
$-1,282.94
FCF Yield
-39.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
84.2%
Operating Margin
-30.4%
Net Margin
-39.6%
ROE
-30.2%
ROA
-15.6%
ROIC
-13.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $38.8M | 85.6% | $-6.1M | $-9.0M | $— | — |
| FY null | $40.0M | 84.2% | $-12.2M | $-15.9M | $— | — |
| Q2 null | $1.2M | 36.4% | $-6.1M | $-6.8M | $— | — |
| Q4 null | $1.5M | 38.1% | $-6.1M | $-5.7M | $— | — |
| FY null | $2.7M | 21.4% | $-11.6M | $-10.1M | $— | — |
| Q2 null | $1.2M | 35.8% | $-5.3M | $-4.2M | $— | — |
| Q4 null | $1.0M | 32.0% | $-7.3M | $-10.0M | $— | — |
| FY null | $1.7M | 0.6% | $-15.3M | $-16.1M | $— | — |
| Q2 null | $654.2K | 41.0% | $-7.8M | $-6.0M | $— | — |
| Q4 null | $2.1M | 50.7% | $-7.8M | $-5.4M | $— | — |
| FY null | $3.1M | 36.5% | $-13.1M | $-6.3M | $— | — |
| Q2 null | $959.0K | 40.0% | $-5.4M | $-883.8K | $— | — |